Ciron Drugs And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 20-06-2024
- Paid Up Capital ₹ 9.50 M
as on 20-06-2024
- Company Age 34 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 21.16 Cr
as on 20-06-2024
- Satisfied Charges ₹ 125.51 Cr
as on 20-06-2024
- Revenue 4.53%
(FY 2022)
- Profit 0.52%
(FY 2022)
- Ebitda 3.22%
(FY 2022)
- Net Worth 22.77%
(FY 2022)
- Total Assets 14.98%
(FY 2022)
About Ciron Drugs And Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.50 M.
The company currently has active open charges totaling ₹21.16 Cr. The company has closed loans amounting to ₹125.51 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kirti Shah, Samir Shah, Keyur Shah, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24246MH1990PTC056735
- Company No.
056735
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jun 1990
- Date of AGM
23 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Ciron Drugs And Pharmaceuticals Private Limited offer?
Ciron Drugs And Pharmaceuticals Private Limited offers a wide range of products and services, including Product Engineering and Prototyping, Electronics Manufacturing Service.
Who are the key members and board of directors at Ciron Drugs And Pharmaceuticals?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samir Shah  | Director | 10-Jul-2000 | Current |
| Keyur Shah | Director | 15-Feb-2016 | Current |
| Kirti Shah | Director | 18-Jun-2005 | Current |
| Madan Hiwale | Director | 12-May-2021 | Current |
| Biswajit Paul | Director | 12-May-2021 | Current |
Financial Performance of Ciron Drugs And Pharmaceuticals.
Ciron Drugs And Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 4.53% increase. The company also saw a slight improvement in profitability, with a 0.52% increase in profit. The company's net worth Soared by an impressive increase of 22.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ciron Drugs And Pharmaceuticals?
In 2022, Ciron Drugs And Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Oboi Laboratories Pvt LtdActive 39 years 5 monthsKirti Shah, Samir Shah and 1 more are mutual person
Cho-Spn Lifescience And Research Private LimitedActive 34 years 2 monthsKirti Shah, Samir Shah and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Oct 2021 | ₹10.00 Cr | Open |
Others Creation Date: 17 Feb 2020 | ₹3.04 M | Open |
Citi Bank N.A. Creation Date: 25 Jul 2018 | ₹10.00 Cr | Open |
How Many Employees Work at Ciron Drugs And Pharmaceuticals?
Unlock and access historical data on people associated with Ciron Drugs And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ciron Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ciron Drugs And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
